期刊文献+

喹硫平致低体温的病例分析及文献复习

Case Analysis and Literature Review of Hypothermia Caused by Quetiapine
原文传递
导出
摘要 目的 提高医务人员对喹硫平引起低体温的认识,为防治该不良反应提供参考。方法 回顾性分析1例因服用喹硫平引起低体温病例的临床表现、诊治经过和药物不良反应因果关系,并结合相关文献复习加以讨论。结果 该患者出现低体温很可能与使用喹硫平有关。抗精神病药引发低体温的主要危险因素包括高龄、合用苯二氮?类药物、亚临床甲状腺功能减退、低温环境暴露等。结论 喹硫平引起患者低体温虽不常见,医务人员仍应加强防范。 OBJECTIVE To improve the medical staff’s understanding of the hypothermia caused by quetiapine and to provide reference for the prevention and treatment of the adverse reaction.METHODS The clinical manifestations,diagnosis,treatment and causality of adverse drug reactions in a case of hypothermia caused by quetiapine were retrospectively analyzed and discussed in combination with related literature review.RESULTS Hypothermia in this patient might be related to the use of quetiapine,and the main risk factors of hypothermia caused by antipsychotics include advanced age,combination of benzodiazepines,subclinical hypothyroidism,hypothermic exposure and so on.CONCLUSION Although hypothermia caused by quetiapine is not common,the prevention should be strengthen by medical staff.
作者 洪顺福 HONG Shunfu(Department of Clinical Pharmacy,Hangzhou Traditional Chinese Medicine Hospital,Hangzhou 310007,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2022年第16期2135-2139,共5页 Chinese Journal of Modern Applied Pharmacy
基金 浙江省中医药科技计划青年人才基金项目(2022ZQ065)。
关键词 喹硫平 低体温 药物不良反应 文献复习 quetiapine hypothermia adverse drug reactions literature review
  • 相关文献

参考文献3

二级参考文献34

  • 1Bandelow B.,Chouinard G.,Bobes J.,et al.Extended-release quetiapine fumarate(quetiapine XR):a once-daily monotherapy effective in generalized anxiety disorder.Data from a randomized,double-blind,placebo-and activecontrolled study[J].The International Journal of Neuropsychopharmacology,2010,13(3):305-320.
  • 2Khan A.,Joyce M.,Atkinson S.,et al.A randomized,double-blind study of once-daily extended release quetiapine fumarate(quetiapine XR)monotherapy in patients with generalized anxiety disorder[J].J Clin Psychopharmacol,2011,31(4):418-28.
  • 3Merideth C.,Cutler A.J.,She F.,et al.Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder:a randomized,placebo controlled and active-controlled study[J].Int Clin Psychopharmacol,2012,27(1):40-54.
  • 4Simon N.M.,Connor K.M.,Le Beau R.T.,et al.Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder:preliminary findings[J].Psychopharmacology(Berl),2008,197(4):675-681.
  • 5Katzman M.,Vermani M.,Jacobs L.,et al.Quetiapine as an adjunctive pharmacotherapy for the treatment of nonremitting generalized anxiety disorder:a flexible-dose,open-label pilot trial[J].Journal of anxiety disorders,2008,22(8):1480-1486.
  • 6Denys D.,de Geus F.,van Megen H.J.,et al.A doubleblind,randomized,placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors[J].Journal of clinical psychiatry,2004,65(8):1040-1048.
  • 7Carey P.D.,Vythilingum B.,Seedat S.,et al.Quetiapine augmentation of SRIs in treatment refractory obsessivecompulsive disorder:a double-blind,randomised,placebo-controlled study[ISRCTN83050762][J].BMC psychiatry,2005,5(1):5.
  • 8Fineberg N.A.,Sivakumaran T.,Roberts A.,et al.Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder:a randomized controlled treatment study[J].Int Clin Psychopharmacol,2005,20(4):223-226.
  • 9Kordon A.,Wahl K.,Koch N.,et al.Quetiapine Addition to Serotonin Reuptake Inhibitors in Patients With Severe Obsessive-Compulsive Disorder:A Double-Blind,Randomized,Placebo-Controlled Study[J].J Clin Psychopharmacol,2008,28(5):550-554.
  • 10de Geus F.,Denys D.,Westenberg H.G.Effects of quetiapine on cognitive functioning in obsessive-compulsive disorder[J].Int Clin Psychopharmacol,2007,22(2):77-84.

共引文献172

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部